Clinical Pharmacology of Aminoglycoside Antibiotics in Pediatrics (Q40145558)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

review article

1 reference

title

Clinical pharmacology of aminoglycoside antibiotics in pediatrics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Clinical Pharmacology of Aminoglycoside Antibiotics in Pediatrics (English)

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

2 October 2023

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338465

2 October 2023

J L Blumer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M. D. Reed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338465

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6338465

2 October 2023

publication date

1 February 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 October 2019

https://api.elsevier.com/content/article/PII:S0031395516343292?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

https://api.elsevier.com/content/article/PII:S0031395516343292?httpAccept=text/plain

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Pediatric Clinics of North America

2 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

195-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Enzymic acetylation of aminoglycoside antibiotics by Excherichia coli carrying an R factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Mechanisms of antibiotic resistance in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Maternal-fetal pharmacological activity of amikacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Tobramycin: maternal-fetal pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Tobramycin sulfate: a summary of worldwide experience from clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Effects of Membrane-Energy Mutations and Cations on Streptomycin and Gentamicin Accumulation by Bacteria: a Model for Entry of Streptomycin and Gentamicin in Susceptible and Resistant Bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Dual Interference of Hygromycin B with Ribosomal Translocation and with Aminoacyl-tRNA Recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Concentration of antibacterial agents in interstitial tissue fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Tobramycin serum levels and tissue content in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Distribution of amikacin in serum, muscle, and fat in children after a single intramuscular injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Transfer of gentamicin to the foetus and the amniotic fluid during a steady state in the mother

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

STUDIES ON THE RIBOSOMES OF STREPTOMYCIN-SENSITIVE AND RESISTANT STRAINS OF ESCHERICHIA COLI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Gentamicin and tobramycin penetration into synovial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Bronchial Secretion Levels of Amikacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

A follow-up study on the cochlear, vestibular and renal function in children treated with gentamicin in the newborn period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Clinical pharmacology of intravenous and intraperitoneal aminoglycoside antibiotics in the prevention of wound infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Penetration of tobramycin into infected extravascular fluids and its therapeutic effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Central nervous system toxicity of intraventricularly administered gentamicin in adult rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Clinical pharmacology of tobramycin in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Streptomycin Uptake via an Inducible Polyamine Transport System in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Use of streptomycin in the treatment of bacterial endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Multiple-compartment pharmacokinetics of tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Placental Transfer and Fetal Urinary Excretion of Gentamicin during Constant Rate Maternal Infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Pharmacokinetics of tobramycin in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

In Vitro Activity, Synergism, and Testing Parameters of Amikacin, with Comparisons to Other Aminoglycoside Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Analysis of gentamicin uptake by rat renal cortical slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

BB-K 8, a new semisynthetic aminoglycoside antibiotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Potentiation of neuromuscular weakness in infant botulism by aminoglycosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Mechanism of action of streptomycin in E. coli: interruption of the ribosome cycle at the initiation of protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Synergy of Penicillin and Gentamicin against Enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Relationship of intraventricular gentamicin levels to cure of meningitis. Report of a case of Proteus meningitis successfully treated with intraventricular gentamicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Effect of aminoglycosides on proximal tubular membranes of the human kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Chloramphenicol-, dihydrostreptomycin-, and kanamycin-inactivating enzymes from multiple drug-resistant Escherichia coli carrying episome 'R'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Experimental studies on the toxicity of kanamycin, its hydrolyzed products and neomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Identification and functional characterization of the protein controlled by the streptomycin-resistant locus in E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Gentamicin and colistin in chronic purulent bronchial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Tobramycin in pediatric use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Are measurements of urine enzymes useful during aminoglycoside therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

RESPIRATORY AND CARDIAC ARREST AFTER INTRAVENOUS ADMINISTRATION OF KANAMYCIN WITH REVERSAL OF TOXIC EFFECTS BY NEOSTIGMINE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

HEARING LOSS IN INFANTS OF TUBERCULOUS MOTHERS TREATED WITH STREPTOMYCIN DURING PREGNANCY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Tissue Persistence of Gentamicin in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Gentamicin disposition and tissue accumulation on multiple dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Accumulation pharmacokinetics of tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Comparative tissue accumulation of gentamicin and tobramycin in patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Gentamicin tissue accumulation and nephrotoxic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Ototoxicity Induced by Furosemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Autoradiography of gentamicin uptake by the rat proximal tubule cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Controlled Comparison of Amikacin and Gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Mechanism of Streptomycin Action on Bacteria: A Unitary Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Enzymes of renal origin in urine as indicators of nephrotoxicity*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Intraventricular use of aminoglycosides in the treatment of gram-negative bacillary meningitis: conflicting views

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Acute renal success. The unexpected logic of oliguria in acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Peripheral inactivation of gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Placental transfer of gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

Pharmacokinetics of tobramycin in the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

The ototoxic effects of kanamycin sulfate in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

The Absorption of Antibiotics from the Bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Ototoxicity of Tobramycin: A Clinical Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934329-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Deafness and Acute Tubular Necrosis Following Parenteral Administration of Neomycin

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

General Mechanisms of Antimicrobial Resistance

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Combined effects of noise and kanamycin

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Inhibition of meningococci by new antimicrobial agents in vitro and recognition of a class of sulfones with a unique mechanism of antibacterial activity

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Clinical Pharmacology of Tobramycin in Newborns

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Severe deafness in an infant following oral administration of neomycin

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Patterns and Mechanisms of Antibiotic Resistance

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Pharmacologic Studies on Tobramycin and Comparison with Gentamicin

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulin

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

Alteration of effectiveness of antibiotics by anaerobiosis

2 October 2023

series ordinal

105

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34329-2

2 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6338465%20AND%20SRC:MED&resulttype=core&format=json